Repligen Corporation
RGEN
$147.06
$6.054.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.49% | 17.36% | 16.36% | 11.74% | 8.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.49% | 17.36% | 16.36% | 11.74% | 8.73% |
| Cost of Revenue | 9.73% | 12.58% | 10.70% | 10.91% | 4.85% |
| Gross Profit | 22.99% | 21.92% | 21.98% | 12.53% | 12.74% |
| SG&A Expenses | 16.52% | 19.20% | 21.56% | 17.20% | 10.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.13% | 16.33% | 16.05% | 14.49% | 7.83% |
| Operating Income | 73.24% | 32.68% | 21.37% | -21.69% | 26.60% |
| Income Before Tax | 483.48% | 346.68% | 330.75% | -65.31% | -152.37% |
| Income Tax Expenses | 4,553.95% | 2,394.82% | 986.85% | -86.42% | -98.62% |
| Earnings from Continuing Operations | 400.42% | 323.66% | 291.64% | 121.47% | -245.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 400.42% | 323.66% | 291.64% | 121.47% | -245.82% |
| EBIT | 73.24% | 32.68% | 21.37% | -21.69% | 26.60% |
| EBITDA | 28.34% | 19.33% | 15.97% | -1.56% | 15.85% |
| EPS Basic | 397.94% | 322.86% | 291.22% | 120.06% | -245.56% |
| Normalized Basic EPS | 38.78% | 18.46% | 15.71% | -34.14% | 6.43% |
| EPS Diluted | 378.04% | 313.10% | 283.88% | 106.99% | -259.00% |
| Normalized Diluted EPS | 38.43% | 18.32% | 15.58% | -34.23% | 6.68% |
| Average Basic Shares Outstanding | 0.41% | 0.49% | 0.53% | 0.53% | 0.52% |
| Average Diluted Shares Outstanding | 0.60% | 0.58% | 0.54% | 0.38% | -0.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |